Profil
Priyanka Mandava formerly worked at Pharmacyclics LLC, as Director from 2013 to 2019, AbbVie, Inc., as Director-Clinical Operations, Pharmacyclics, Inc., as Director-Clinical Operations, Summit Therapeutics, Inc., as Vice President-Global Clinical Operations from 2021 to 2022, and Biomea Fusion, Inc., as Vice President-Clinical Operations from 2022 to 2025.
Anciens postes connus de Priyanka Mandava
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMEA FUSION, INC. | Directeur Technique/Scientifique/R&D | 01/02/2025 |
| SUMMIT THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/03/2022 |
| PHARMACYCLICS, INC. | Directeur/Membre du Conseil | 01/08/2019 |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Directeur Technique/Scientifique/R&D | - |
| ABBVIE INC. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Summit Therapeutics, Inc.
Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Biomea Fusion, Inc.
Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Health Technology |
















